Atorvastatin Calcium
Product Images NDC 60760-979

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 60760-979). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atorv (Atorvastatin 60760 979 30)

This is a description of Atorvastatin, which is a type of medication used for the treatment of high cholesterol and heart diseases. It is available in tablet form with different dosages of calcium and is prescribed by a healthcare professional using a managed pharmacy program. The medication should be stored in a controlled room with a temperature range specified on the package. The provided text also includes information about the product code, strength, and prescription referral numbers.*

FDA Label Image

Figure-01 (Atorvastatin Figure 01)

FDA Label Image

Figure-02 (Atorvastatin Figure 02)

This document appears to present a graph or chart that shows cumulative hazard percentages over a period of time. It also includes some numerical values and a statistical analysis result in the form of a Hazard Ratio and corresponding p-value. The document appears to relate to some type of medical or scientific research study involving the tracking of primary endpoints over a four-year period.*

FDA Label Image

Figure-03 (Atorvastatin Figure 03)

This is a tabular representation of the percentage of subjects experiencing an event after taking two different doses of Atorvastatin (10mg and 80mg). The data shows that there were no events experienced by subjects who took 10mg of Atorvastatin. However, there were events experienced by subjects who took 80mg of Atorvastatin, but the hazard ratio was 0.78 (0.69-0.89) with a P-value of 0.0002. The table also shows the time to the first major cardiovascular endpoint in years.*

FDA Label Image

Structure (Atorvastatin Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.